antinociceptive and antitumor activity of novel synthetic mononuclear ruthenium (ii) compounds

نویسندگان

shyam sunder anchuri department of pharmacology and pharmaceutical chemistry, s. r college of pharmacy, ananthasagar, warangal and department of pharmacy, acharya nagarjuna university, guntur, india

satyavathi dhulipala department of pharmacology, teegala krishna reddy college of pharmacy, meerpet, hyderabad, andhra pradesh, india

sreekanth thota department of pharmacology and pharmaceutical chemistry, s. r college of pharmacy, ananthasagar, warangal,india

rajeshwar yerra department of pharmacology and pharmaceutical chemistry, s. r college of pharmacy, ananthasagar, warangal,india

چکیده

normal 0 false false false en-us x-none ar-sa background: from the thousands of years, metal compounds have been used in medicine for treatment of various diseases including various types of cancers. ruthenium was seen as a promising metal due to its similar kinetics to platinum and its lower toxicity. therefore, we aimed to evaluate the newer mononuclear ruthenium (ii) compounds for antinociceptive and antitumor activities. materials and methods: ruthenium (ii) compounds were evaluated for antinociceptive and antitumor activity using the various in vitro and in vivo models. the compounds were injected to mice at concentrations of 1 and 2 mg kg -1 intraperitoneally and were screened for antinociceptive activity, and the antiproliferative effect was evaluated against murine leukemia cells (l1210), human t-lymphocyte cells (cem) and human cervix carcinoma cells (hela) using mtt assay. results: the results for antitumor activity clearly indicated that compound r 1 was potent cytotoxic agent than r 2 with ic 50 values ranging from 4-6 µm for r 1 , whereas ic 50 values for compound r 2 ranging from 65-103 µm. the compounds have shown a significant anti-inflammatory effect in carrageenan and dextran models but do not having the central analgesic activity, this indicating that the antinociceptive activity is related to the peripheral nervous system. the results for 5-lipoxygenase (5-lox) activity showed that both r 1 and r 2 compounds were found to be significant 5-lox inhibitory activity with ic 50 values of 14.35 µg.ml -1 and 29.24 µg.ml -1 respectively. conclusion: these findings concluded that the new ruthenium compounds might be the promising antiproliferative agents as these compounds showing significant 5-lox inhibitory activity and potential agents in the management of pain related disorders.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Antinociceptive and antitumor activity of novel synthetic mononuclear Ruthenium (II) compounds

BACKGROUND From the thousands of years, metal compounds have been used in medicine for treatment of various diseases including various types of cancers. Ruthenium was seen as a promising metal due to its similar kinetics to platinum and its lower toxicity. Therefore, we aimed to evaluate the newer mononuclear ruthenium (II) compounds for antinociceptive and antitumor activities. MATERIALS AND...

متن کامل

Novel mononuclear ruthenium(II) compounds in cancer therapy.

The present study was conducted to evaluate in vivo anticancer activity of two novel mononuclear ruthenium(II) compounds, namely Ru(1,10-phenanthroline)2(2-nitro phenyl thiosemicarbazone)Cl2 (Compound R1) and Ru (1,10-phenanthroline)2(2-hydroxy phenyl thiosemicarbazone)Cl2 (Compound R2) against Ehrlich ascites carcinoma (EAC) mice and in vitro cytotoxic activity against IEC-6 (small intestine) ...

متن کامل

Tetrocarcins, novel antitumor antibiotics. II. Isolation, characterization and antitumor activity.

Novel antitumor antibiotics, tetrocarcin complex composed of three components (A, B and C) were isolated from the culture broth of Micromonospora chalcea KY11091 through various procedures. Tetrocarcins showed marked activity against experimental tumors such as mouse sarcoma 180 and mouse leukemia P388. Multiple injections showed better therapeutic effect against tumors. Mode of action of tetro...

متن کامل

Synthesis, Characterization, and Antitumor Activity of Four Novel Sulphonamide compounds

Abstract: A selected series of substituted sulphonamides were synthesized. These compounds were tested for potential antitumor activity against three of human tumor cell lines, Liver carcinoma cell line [HEPG2], Brain tumor cell line [U251] and Colon carcinoma cell line [HCT116]. Cytotoxic activity was assessed by SRB assay. The structures of the resulting compounds have been investigated by el...

متن کامل

Organometallic ruthenium(II) arene compounds with antiangiogenic activity.

The antimetastatic ruthenium(II) compounds [Ru(η(6)-p-cymene)Cl(2)(PTA)] (PTA = 1,3,5-triaza-7-phosphaadamantane) (RAPTA-C) and [Ru(η(6)-toluene)Cl(2)(PTA)] (RAPTA-T), as well as their analogues [Ru(η(6)-p-cymene)Cl(2)(DAPTA)] (DAPTA = (3,7-diacetyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane)) (DAPTA-C) and [Ru(η(6)-toluene)Cl(2)(DAPTA)] (DAPTA-T), respectively, were tested in in vitro bioassay...

متن کامل

comparison of catalytic activity of heteropoly compounds in the synthesis of bis(indolyl)alkanes.

heteropoly acids (hpa) and their salts have advantages as catalysts which make them both economically and environmentally attractive, strong br?nsted acidity, exhibiting fast reversible multi-electron redox transformations under rather mild conditions, very high solubility in polar solvents, fairly high thermal stability in the solid states, and efficient oxidizing ability, so that they are imp...

15 صفحه اول

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
journal of research in medical sciences

جلد ۱۸، شماره ۳، صفحات ۲۱۵-۰

کلمات کلیدی
[ 5 , ' l o x ' , ' a n t i n o c i c e p t i o n ' , ' m t t ' , ' r u t h e n i u m c o m p o u n d s ' ]

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023